Member access

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  GlaxoSmithKline plc    GS7   GB0009252882

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo GlaxoSmithKline plc
Develops, manufactures and distributes vaccines and other pharmaceutical products

GlaxoSmithKline Plc operates as a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands.

It operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare.

The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases.

The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis.

The Consumer Healthcare business markets a range of consumer health products based on scientific innovation.

The company was founded on December 6, 1999 and is headquartered in Brentford, the United Kingdom.
Officers and Executives
NameAgeOfficer SinceTitle
Andrew Philip Witty49-Chief Executive Officer & Executive Director
Christopher Charles Gent65-Non-Executive Chairman
Simon Dingemans50-Chief Financial Officer & Executive Director
Moncef Slaoui, PhD65-Director, Chairman-Global Research & Development
William C. Louv, PhD--Chief Information Officer
James Samuel Shannon, MD58-Chief Medical Officer
Deryck Charles Maughan66-Independent Non-Executive Director
Robert Peter Wilson71-Senior Independent Non-Executive Director
Crispin H. L. Davis64-Independent Non-Executive Director
Tom de Swaan68-Independent Non-Executive Director
Surperformance© rating of GlaxoSmithKline plc
Overall rating In sector In country
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector
Healthcare
Biotechnology / Pharmaceuticals
 Biotechnology / Pharmaceuticals
  Pharmaceuticals - Diversified
Shareholders
- Blackrock 5,52%
- Legal & General 3,12%
Advertisement
Sector Pharmaceuticals - Diversified
Trading RatingInvestor Rating
JOHNSON & JOHNSON
ROCHE HOLDING LTD..
NOVARTIS AG
PFIZER INC.
MERCK & CO., INC.
Sector Pharmaceuticals - Diversified
Company contact information
980 Great West road
TW8 9GS Brentford, Greater London
Great-Britain

Phone : +44 (0)20 8047 5000
Fax : +44 (0)20 8047 7807
Internet : http://www.gsk.com
Markets and indexes
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE Eurotop 100, Stoxx 50, Stoxx Global 200, Stoxx UK 50
Stock Exchange Codes
- ISIN Code :  GB0009252882
- Bloomberg Code :  GSK:LN
- Reuters Code :  GSK.L
- Datastream Code :  GSK
© 2014 Factset    © 2014 Cofisem   
Dynamic quotes  
ON
| OFF